Delivery Order SPE2DR25D2014-SPE2DR26FA0L6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,755.66 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). The contract was competitively awarded without set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of December 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,165.67 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on December 2, 2025, with completion scheduled for December 3, 2025. This competitive delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the...
- The Defense Logistics Agency awarded a delivery order valued at $2,935.98 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. This non-competitive delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction under AmerisourceBergen's larger pharmaceutical supply contract. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8,743.46 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. The contract was competitively awarded without set-aside designation under firm fixed price terms, with an ultimate completion date of December 8, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $57,380.66 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) with a completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 18, 2025, for 90-count tablets of Jardiance 10 mg. This firm fixed-price delivery order has a ceiling value of $6,807.46 and is scheduled for completion by November 19, 2025. The contract does not include a set-aside designation, indicating it was awarded through open competition. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package at a ceiling value of $1,636.36. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,024.03 by the Defense Logistics Agency on September 18, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract is non-set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement, with an ultimate completion date of September 19, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0L6Delivery Order
This delivery order, valued at $8,006.67, awards AmerisourceBergen Drug Corp the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract with the Defense Logistics Agency. The order was competitively awarded without set-aside restrictions and is scheduled for completion by December 22, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.9 million through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and healthcare systems, supplying an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of products to military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to compete successfully for federal pharmaceutical procurement across diverse product categories and contract values reflects its role as a major vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 12/18/25 |